Page 48 - கொலம்பியா பல்கலைக்கழகம் இவிஂக் மருத்துவ மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

TransMedics Announces Positive FDA Advisory Committee Vote for OCS Heart System Panel votes 12 to 5 that benefits of OCS Heart System outweigh risks News provided by Share this article Share this article ANDOVER, Mass., April 6, 2021 /PRNewswire/  TransMedics Group, Inc. ( TransMedics ) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that after the review of TransMedics clinical evidence from the OCS Heart EXPAND trial, the associated Continued Access Protocol ( CAP ) results, as well as the OCS Heart PROCEED II trial, the Circulatory Systems Device Advisory Panel convened by the U.S. Food and Drug Administration ( FDA ) has issued a favorable vote in support of approval of the OCS Heart System to the FDA s Office of Health Technology 2 (Cardiovascular Devices). The panel voted 12 to 5, with 1 abstaining, that the benefits of the OCS Heart System outweigh i

United statesMaryjane farrWaleed hassaneinJacob schroderColumbia university irving medical centerAdvisory panel meetingDuke university medical centerAdvisory panelTransmedics group incChief executivePanel meetingColumbia university irving medicalPrimary graft dysfunctionTransmedics groupஒன்றுபட்டது மாநிலங்களில்மேரி ஜேன் ஃபார்